- Home
- NMT vs KRRO Comparison
NMT vs KRRO Comparison
Compare NMT & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMT | KRRO |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.8M | 101.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | NMT | KRRO |
|---|---|---|
| Price | $11.73 | $12.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $54.60 |
| AVG Volume (30 Days) | 19.1K | ★ 307.3K |
| Earning Date | 01-01-0001 | 03-17-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,371,000.00 |
| Revenue This Year | N/A | $145.49 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.05 | $5.20 |
| 52 Week High | $10.93 | $55.89 |
Technical Indicators
Market Signals| Indicator | NMT | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 66.03 | 63.53 |
| Support Level | $11.60 | $9.88 |
| Resistance Level | $11.72 | $14.94 |
| Average True Range (ATR) | 0.12 | 1.05 |
| MACD | 0.02 | 0.41 |
| Stochastic Oscillator | 86.94 | 60.34 |
Price Performance
Historical ComparisonAbout NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.